UK buyers are told to acknowledge Conformatie Europeane (CE) marking:
This article was originally published in Clinica
Executive Summary
UK NHS purchasing authority chief executives have been told to give equal weight to CE-marked devices as to those on the UK Manufacturer Registration Scheme (MRS) when making buying decisions. In his letter to the managers, Medical Devices Agency chief executive Alan Kent asks for action to ensure those with purchasing responsibility are made aware of the CE- marking and the MDA's support of it. It had been Department of Health policy, prior to the introduction of the medical device Directives, to recommend that medical devices be purchased only from manufacturers with MRS registration.
You may also be interested in...
Sanofi Skates To Where The Puck Is With Immunology
The French drugmaker has not abandoned oncology but has made it very clear that immunology and inflammation is the priority for its R&D euros.
Pipeline Watch: Five Approvals And 23 Phase III Updates
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
Lack Of Industry Involvement In EU HTA Scoping Process Exacerbates ‘Unworkable’ Timelines
Scientific advice could help companies make up for the lack of involvement in scoping, but slots are in short supply.